- Home
- / Angiex
Angiex
Total Funding
$2.9 M
Angiex Summary
Company Summary
- Overview
- Angiex is a company developing vascular-targeted biotherapeutics. Its lead product is an antibody-drug conjugate therapy for cancer.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://angiex.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Cambridge, MA HQ
United States
700 Main St
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026